BIOLOGICAL EVALUATION OF GLYCOGEN SYNTHASE KINASE-3 Β INHIBITORS AS ANTIDIABETIC AGENT

Authors

  • Jeeven S. Solanki Department of Chemistry, Govt. Madhav Science P.G. College Ujjain (M.P.) Pin 456010, India
  • Arpan Bhardwaj Department of Chemistry, Govt. Madhav Science P.G. College Ujjain (M.P.) Pin 456010, India
  • Amit Padidar Department of Chemistry, Govt. Madhav Science P.G. College Ujjain (M.P.) Pin 456010, India
  • Kalpana Singh Department of Chemistry, Govt. Madhav Science P.G. College Ujjain (M.P.) Pin 456010, India
  • Rekha Nagwanshi Department of Chemistry, Govt. Madhav Science P.G. College Ujjain (M.P.) Pin 456010, India

DOI:

https://doi.org/10.29121/ijetmr.v4.i12.2017.584

Keywords:

Phenylmethylenehydantoin, Phenylmethylenerhodanine, Antidiabetic, GSK-3β

Abstract

A series of phenylmethylenehydantoin and phenylmethylenerhodanine derivatives (Der 1 to
Der 8) were synthesized. These newly synthesized derivatives have been characterized by
elemental analysis molecular weight measurements as well as spectral (IR, 1H NMR
13CNMR) studies. All the compounds show significant increase in liver glycogen level at 25
mg/kg dose levels, in- vivo & these compounds were also screened for anti diabetic activity on
albino rats. Most of these compounds have shown significant antidiabetic activity at 25 mg/kg
dose levels.

Downloads

Download data is not yet available.

References

Khanfar, A. M.; Bilal, A. A.; Mudit, M.; Kaddoumi A.; Khalid A. E., Bioorg. Med. Chem., 2009, 17, 6032–6039. DOI: https://doi.org/10.1016/j.bmc.2009.06.054

Sivaprakasama, P.; Aihua, X.; Robert, J. D., Bioorg. Med. Chem., 2006, 14, 8210–8218.

Denise, M. F.; David, K., Dev. Biol., 2000, 225, 471–479.

Vats, R. K.; Kumar, V.; Kothari, A.; Mital, A.; Ramachandran, U., Curr. Sc., 2005, 88, 241-249.

Pattan, S. R.; Suresh, C.; Pujar, V. D.; Reddy, V. V. K.; Rasal, V. P.; Koti, B. C., Indian J. Chem., 2005, 44B, 2404-2408.

Sheelagh, F.; Philip, C., Biochem. J., 2001, 359, 1-16. DOI: https://doi.org/10.1023/A:1011060903627

Laurent, M.; Marc, F.; Paul, G., Trends Pharmacol. Sci., 2004, 25, 471-480.

Li, S.; Ngoc, T.; Flora, T.; Herald, A.; Pter, H.; Gerald, M.; Cho, T., J. Med. Chem., 1998, 41, 2588-2603.

Bastaki, S., Int. J. Diabetes Metabolism, 2005, 13, 111-134. DOI: https://doi.org/10.1159/000497580

Ballard, A.M., Clin. Diabetes, 2000.

Gerald, I. S., J. Clin. Invest. 2000, 106, 171-176.

Modi, P., Curr. Drug Discov. Tech., 2007, 4, 39-47. DOI: https://doi.org/10.2174/157016307781115476

Clifford, J. B.; Caroline, D., Br. J. Cardiol., 2003, 10,128–136.

Sarabu, R.; Tilley, J., Annu. Rep. Med. Chem., 2005, 40, 167-178. DOI: https://doi.org/10.1016/S0065-7743(05)40011-1

Hendrik, S.; Rainer, M.; Marcus, G.; Yoan, F.; Olivier, L.; Thomas, L.; Simone, K.; Alexander, L.; Ulrike, B.; Cord, D.; Laurent M.; Matthias, A.; Conrad, K., J. Med. Chem., 2008, 51, 2196–2207.

Ana, M.; Mercedes, A.; Ana, C.; Concepcion, P.; Francisco, J. M., J. Med. Chem., 2002, 45, 1292-1299.

Downloads

Published

2017-12-31

How to Cite

Solanki, J. S., Bhardwaj, A. ., Padidar , A. ., Singh, K. ., & Nagwanshi, R. . (2017). BIOLOGICAL EVALUATION OF GLYCOGEN SYNTHASE KINASE-3 Β INHIBITORS AS ANTIDIABETIC AGENT. International Journal of Engineering Technologies and Management Research, 4(12), 1–12. https://doi.org/10.29121/ijetmr.v4.i12.2017.584

Issue

Vol. 4 No. 12 (2017): IJETMR: Volume 4 Issue 12 - December Special Edition, 2017

Section

Articles

License

License and Copyright Agreement

In submitting the manuscript to the journal, the authors certify that:

  • They are authorized by their co-authors to enter into these arrangements.
  • The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
  • That it is not under consideration for publication elsewhere.
  • That its release has been approved by all the author(s) and by the responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
  • They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
  • They agree to the following license and copyright agreement.

Copyright

Authors who publish with International Journal of Engineering Technologies and Management Research agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  • Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

For More info, please visit CopyRight Section

Crossref
Scopus
Google Scholar
Europe PMC